M&A

St. Jude Medical Completes Acquisition of Spinal Modulation, Inc.
Yahoo
Tue, 05/5/15 - 09:10 am
St. Jude Medical
Spinal Modulation
M&A
devices
What's Mylan worth? For big exec bonuses, $73 per share. For Teva, lots more
Fierce Pharma
Mon, 05/4/15 - 11:30 am
Mylan
Teva Pharmaceutical
M&A
executive pay
Patterson to buy private veterinary products maker for $1.1 bln
Yahoo/Reuters
Mon, 05/4/15 - 09:45 am
Patterson Companies
animal health
M&A
Animal Health International
Are Drug Mergers In Their Final Act?
Yahoo/Investors.com
Sat, 05/2/15 - 01:19 pm
M&A
Mylan Disagrees With Itself in Effort to Spurn Teva Takeover
Bloomberg
Sat, 05/2/15 - 01:16 pm
Mylan
M&A
Teva Pharmaceutical
AbbVie Again Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Marketwatch
Sat, 05/2/15 - 01:14 pm
AbbVie
Pharmacyclics
M&A
Pfizer emerges as mystery bidder for rare disease firm Swedish Orphan
BioPharma Dive
Fri, 05/1/15 - 10:17 am
Pfizer
M&A
Swedish Orphan Biovitrum
Sobi
Teva CEO 'takes the high road' to rebut Mylan chairman's attack
Fierce Pharma
Fri, 05/1/15 - 08:55 am
Teva Pharmaceutical
Mylan
Pharma CEOs
M&A
Erez Vigodman
Smith & Nephew 'working hard' on acquisitions trail, CEO says
Mass Device
Thu, 04/30/15 - 02:10 pm
Smith & Nephew
M&A
devices
Olivier Bohuon
Teva isn't going away quietly
Bizjournals.cm
Thu, 04/30/15 - 12:39 pm
Teva Pharmaceutical
Mylan
M&A
Scorecard Of Biobuck M&A Earnouts
Forbes
Thu, 04/30/15 - 10:56 am
M&A
Teva lifts 2015 earnings forecast as pursues Mylan bid
Yahoo/Reuters
Thu, 04/30/15 - 10:47 am
Teva Pharmaceutical
Mylan
M&A
earnings
Exclusive - Perrigo expected to reject Mylan's latest offer: source
Yahoo/Reuters
Wed, 04/29/15 - 10:35 am
Perrigo
Mylan
M&A
Mylan Increases Takeover Bid for Perrigo to $32.7 Billion
Yahoo/Bloomberg
Wed, 04/29/15 - 10:11 am
Mylan
Perrigo
M&A
Mylan’s Objections to Teva’s Offer
Yahoo/Market Realist
Tue, 04/28/15 - 09:19 pm
Mylan
Teva Pharmaceutical
M&A
Will Pfizer Relaunch Its AstraZeneca Bid?
Seeking Alpha
Tue, 04/28/15 - 09:02 pm
Pfizer
AstraZeneca
M&A
Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A - bankers
Yahoo/Reuters
Tue, 04/28/15 - 09:53 am
Sun Pharma
India
Ranbaxy
M&A
Mylan rejects Teva's $40.1 billion buyout offer
Yahoo/AP
Mon, 04/27/15 - 10:56 am
Mylan
Teva Pharmaceutical
M&A
Celgene bags a build-to-buy biotech in $485M cancer deal
Fierce Biotech
Mon, 04/27/15 - 09:49 am
Celgene
M&A
Quanticel Pharmaceuticals
cancer
R&D
Straight-Talking Teva Boss May Find Mylan Toughest Target
Bloomberg
Mon, 04/27/15 - 09:48 am
Teva Pharmaceutical
Mylan
M&A
Erez Vigodman

Pages